{"count": 4, "results": [{"_id": "33116554", "pmid": 33116554, "pmcid": "PMC7585262", "title": "The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly", "journal": "Vasc Health Risk Manag", "authors": ["Aleidan FAS"], "date": "2020-10-19T00:00:00Z", "doi": "10.2147/VHRM.S264814", "meta_date_publication": "2020", "meta_volume": "16", "meta_issue": "", "meta_pages": "437-443", "score": 50277.21, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ may have a protective effect against recurrent @<m>DISEASE_Venous_Thromboembolism</m> @DISEASE_MESH:D054556 @@@VTE@@@ in the elderly population, and a larger study is needed to validate our findings.", "citations": {"NLM": "Aleidan FAS. The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly Vasc Health Risk Manag. 2020;16():437-443. PMID: 33116554", "BibTeX": "@article{33116554, title={The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly}, author={Aleidan FAS}, journal={Vasc Health Risk Manag}, volume={16}, pages={437-443}}"}}, {"_id": "41017352", "pmid": 41017352, "title": "[Effect of metformin on the incidence of venous thromboembolism in medical inpatients during hospitalization].", "journal": "Zhonghua Yi Xue Za Zhi", "authors": ["Huang WY", "Yan XY", "Chen YR"], "date": "2025-09-23T00:00:00Z", "doi": "10.3760/cma.j.cn112137-20250503-01104", "meta_date_publication": "2025 Sep 23", "meta_volume": "105", "meta_issue": "36", "meta_pages": "3208-3213", "score": 50271.492, "text_hl": "[Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the incidence of @<m>DISEASE_Venous_Thromboembolism</m> @DISEASE_MESH:D054556 @@@venous thromboembolism@@@ in medical inpatients during hospitalization].", "citations": {"NLM": "Huang WY, Yan XY, Chen YR. [Effect of metformin on the incidence of venous thromboembolism in medical inpatients during hospitalization]. Zhonghua Yi Xue Za Zhi. 2025 Sep 23;105(36):3208-3213. PMID: 41017352", "BibTeX": "@article{41017352, title={[Effect of metformin on the incidence of venous thromboembolism in medical inpatients during hospitalization].}, author={Huang WY and Yan XY and Chen YR}, journal={Zhonghua Yi Xue Za Zhi}, volume={105}, number={36}, pages={3208-3213}}"}}, {"_id": "34999759", "pmid": 34999759, "title": "Association of Metformin Use With Risk of Venous Thromboembolism in Adults With Type 2 Diabetes: A General-Population-Based Cohort Study.", "journal": "Am J Epidemiol", "authors": ["Sha T", "Zhang Y", "Li C", "Lei G", "Wu J", "Li X", "Yang Z", "Zeng C", "Wei J"], "date": "2022-03-24T00:00:00Z", "doi": "10.1093/aje/kwab291", "meta_date_publication": "2022 Mar 24", "meta_volume": "191", "meta_issue": "5", "meta_pages": "856-866", "score": 50256.01, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is hypothesized to protect against the risk of @<m>DISEASE_Venous_Thromboembolism</m> @DISEASE_MESH:D054556 @@@venous thromboembolism@@@ (@<m>DISEASE_Venous_Thromboembolism</m> @DISEASE_MESH:D054556 @@@VTE@@@); however, there is a paucity of data supporting this hypothesis. ", "citations": {"NLM": "Sha T, Zhang Y, Li C, Lei G, Wu J, Li X, Yang Z, Zeng C, Wei J. Association of Metformin Use With Risk of Venous Thromboembolism in Adults With Type 2 Diabetes: A General-Population-Based Cohort Study. Am J Epidemiol. 2022 Mar 24;191(5):856-866. PMID: 34999759", "BibTeX": "@article{34999759, title={Association of Metformin Use With Risk of Venous Thromboembolism in Adults With Type 2 Diabetes: A General-Population-Based Cohort Study.}, author={Sha T and Zhang Y and Li C and Lei G and Wu J and Li X and Yang Z and Zeng C and Wei J}, journal={Am J Epidemiol}, volume={191}, number={5}, pages={856-866}}"}}, {"_id": "26642102", "pmid": 26642102, "title": "AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.", "journal": "Endocr Pract", "authors": ["Goodman NF", "Cobin RH", "Futterweit W", "Glueck JS", "Legro RS", "Carmina E", "American Association of Clinical Endocrinologists (AACE)", "American College of Endocrinology (ACE)", "Androgen Excess and PCOS Society"], "date": "2015-12-01T00:00:00Z", "doi": "10.4158/EP15748.DSCPT2", "meta_date_publication": "2015 Dec", "meta_volume": "21", "meta_issue": "12", "meta_pages": "1415-26", "score": 50016.293, "text_hl": "Subjects with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ have a 1.5-times higher baseline risk of @<m>DISEASE_Venous_Thromboembolism</m> @DISEASE_MESH:D054556 @@@venous thromboembolic disease@@@ and a 3.7-fold greater effect with OCP use compared with non-@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ subjects. ", "citations": {"NLM": "Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocr Pract. 2015 Dec;21(12):1415-26. PMID: 26642102", "BibTeX": "@article{26642102, title={AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.}, author={Goodman NF and Cobin RH and Futterweit W and Glueck JS and Legro RS and Carmina E and American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) and Androgen Excess and PCOS Society}, journal={Endocr Pract}, volume={21}, number={12}, pages={1415-26}}"}}]}